PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Pathologists awarded grant from American Society of Hematology

2024-06-26
(Press-News.org) Dr. Zhen Mei, a clinical pathologist, and Dr. Vivian Chang, a pediatric hematologist-oncologist, both at UCLA Health, have been awarded $30,000 from the American Society of Hematology to revise blood cell ranges for people with Duffy-null Associated Neutrophil Count, which is also known as Duffy-negative.

Those who are Duffy-negative, estimated to be two out of three people identifying as Black in the U.S., lack Duffy antigens on the surface of their red blood cells as a mechanism to resist malaria. This helps provide protection but also disrupts the body’s chemical signaling to keep neutrophils — a type of white blood cell — in blood vessels. As a result, Duffy-negative blood samples can appear to have a dangerously low white blood cell count, though those cells reside in other parts of the body.

Under current blood cell ranges, Duffy-negative people are often misdiagnosed with neutropenia, leading to unnecessary medical procedures, exclusion from clinical trials and undue stress. To amend the ranges, the study team will collect and test blood samples for Duffy status, and assess the normal neutrophil count for the population group.

“In the future, if we see a blood sample with a low neutrophil count, we should test it for Duffy status,” Mei said. “If the sample is Duffy-negative, we should apply the appropriate reference range for that patient.”

Dr. Zhen Mei, a clinical pathologist, and Dr. Vivian Chang, a pediatric hematologist-oncologist, both at UCLA Health, have been awarded $30,000 from the American Society of Hematology to revise blood cell ranges for people with Duffy-null Associated Neutrophil Count, which is also known as Duffy-negative.

Those who are Duffy-negative, estimated to be two out of three people identifying as Black in the U.S., lack Duffy antigens on the surface of their red blood cells as a mechanism to resist malaria. This helps provide protection but also disrupts the body’s chemical signaling to keep neutrophils — a type of white blood cell — in blood vessels. As a result, Duffy-negative blood samples can appear to have a dangerously low white blood cell count, though those cells reside in other parts of the body.

Under current blood cell ranges, Duffy-negative people are often misdiagnosed with neutropenia, leading to unnecessary medical procedures, exclusion from clinical trials and undue stress. To amend the ranges, the study team will collect and test blood samples for Duffy status, and assess the normal neutrophil count for the population group.

“In the future, if we see a blood sample with a low neutrophil count, we should test it for Duffy status,” Mei said. “If the sample is Duffy-negative, we should apply the appropriate reference range for that patient.”

END


ELSE PRESS RELEASES FROM THIS DATE:

Revolutionizing ovarian cancer treatment with adaptive PARP inhibitor therapy

2024-06-26
TAMPA, Fla. — Ovarian cancer, often diagnosed at an advanced stage, presents significant treatment challenges because patients tend to develop resistance to conventional therapies quickly. Despite aggressive treatment, recurrence rates remain high, and managing this disease effectively requires innovative approaches. Poly-adenosine ribose polymerase (PARP) inhibitors have emerged as a treatment option, targeting specific DNA repair mechanisms in cancer cells. However, their use is often limited ...

Global consensus for sarcopenia

Global consensus for sarcopenia
2024-06-26
“[...] the development of a global conceptual definition of sarcopenia signifies a new dawn for this muscle disease.” BUFFALO, NY- June 26, 2024 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 11, entitled, “Global consensus for sarcopenia.” In this new editorial, researchers Ben Kirk, Peggy M. Cawthon, and Alfonso J. Cruz-Jentoft from the University of Melbourne and Western Health discuss the global societal issue of skeletal muscle loss and weakness, termed Sarcopenia. Low muscle ...

Ocean’s loss of oxygen caused massive Jurassic extinction. Could it happen again?

Ocean’s loss of oxygen caused massive Jurassic extinction. Could it happen again?
2024-06-26
DURHAM, NC – Researchers have discovered a clue in Italian limestone that helps explain a mass extinction of marine life millions of years ago, and may provide warnings about how oxygen depletion and climate change could impact today’s oceans. “This event, and events like it, are the best analogs we have in Earth's past for what is to come in the next decades and centuries,” said Michael A. Kipp, an earth and climate science assistant professor at Duke University. Kipp co-authored a study published  June 24 in the Proceedings of the National Academy of Sciences  that measures oxygen loss ...

Shocked quartz reveals evidence of historical cosmic airburst

Shocked quartz reveals evidence of historical cosmic airburst
2024-06-26
(Santa Barbara, Calif.) — Researchers continue to expand the case for the Younger Dryas Impact hypothesis. The idea proposes that a fragmented comet smashed into the Earth’s atmosphere 12,800 years ago, causing a widespread climatic shift that, among other things, led to the abrupt reversal of the Earth’s warming trend and into an anomalous near-glacial period called the Younger Dryas.  Now, UC Santa Barbara emeritus professor James Kennett and colleagues report the presence of proxies associated with the cosmic airburst ...

Chemotherapy disrupts gut microbiome in patients with breast cancer

Chemotherapy disrupts gut microbiome in patients with breast cancer
2024-06-26
COLUMBUS, Ohio – Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition. “For the first time ever, our Intelligut Study found that the gut microbiome has been implicated in cognitive side effects of chemotherapy in humans,” said senior author Leah Pyter, associate professor of psychiatry and neuroscience with The Ohio State University Wexner Medical Center and College of Medicine. ...

Microrobot-packed pill shows promise for treating inflammatory bowel disease in mice

2024-06-26
Engineers at the University of California San Diego have developed a pill that releases microscopic robots, or microrobots, into the colon to treat inflammatory bowel disease (IBD). The experimental treatment, given orally, has shown success in mice. It significantly reduced IBD symptoms and promoted the healing of damaged colon tissue without causing toxic side effects. The study was published June 26 in Science Robotics. IBD, an autoimmune disorder characterized by chronic inflammation of the gut, ...

Sharing false political information on social media may be associated with positive schizotypy

Sharing false political information on social media may be associated with positive schizotypy
2024-06-26
Sharing false political information on social media by users may be associated with aspects of personality such as positive schizotypy, a set of traits including paranoia, suspicion and disrupted thinking patterns. It may also be linked to a motivation to increase awareness according to a study published June 26, 2024 in the open-access journal PLOS ONE by Tom Buchanan, University of Westminster, UK, and colleagues. The spread of false political information on social media can tarnish trust in authentic news and even contribute to social unrest. Knowingly or not, a small portion of social media users actively share false material. Buchanan and ...

AI-generated exam submissions evade detection at reputable UK university

AI-generated exam submissions evade detection at reputable UK university
2024-06-26
In a test of the examinations system of the University of Reading in the UK, artificial intelligence (AI)-generated submissions went almost entirely undetected, and these fake answers tended to receive higher grades than those achieved by real students. Peter Scarfe of the University of Reading and colleagues present these findings in the open-access journal PLOS ONE on June 26. In recent years, AI tools such as ChatGPT have become more advanced and widespread, leading to concerns about students using them to cheat by submitting AI-generated work as their own. Such concerns are heightened ...

The on-and-off affair in DNA

The on-and-off affair in DNA
2024-06-26
Researchers led by Kannosuke Yabe, Asuka Kamio, and Soichi Inagaki of the University of Tokyo have discovered that in thale cresses histone H3 lysine-9 (H3K9) methylation, conventionally thought to be a mark of turning off gene transcription, can also turn on gene expression via the interactions of two other proteins and histone marks. The molecular mechanisms demonstrate that rather than functioning as a simple “off switch,” H3K9 methylation is more like a “dimmer switch” that fine-tunes DNA transcription. The discovery suggests there might be similar mechanisms in other ...

New interactive atlas of water scarcity solutions in the US Southwest shares a library of case studies to help adapt to drought

New interactive atlas of water scarcity solutions in the US Southwest shares a library of case studies to help adapt to drought
2024-06-26
New interactive atlas of water scarcity solutions in the U.S. Southwest shares a library of case studies to help adapt to drought. #### Article URL: https://journals.plos.org/water/article?id=10.1371/journal.pwat.0000246 Article Title: The water adaptation techniques atlas: A new geospatial library of solutions to water scarcity in the U.S. Southwest Author Countries: United States Funding: The authors have declared that no competing interests exist. END ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Pathologists awarded grant from American Society of Hematology